Inquirer
With obesity rising as a major driver of chronic disease and healthcare burden in the Philippines, Novo Nordisk today launched the Live Lighter movement, a multi-sector initiative aimed at transforming both public understanding and access to care. Unveiled at a media launch in Makati City, the initiative calls for a shift in perspective: from viewing obesity as a matter of personal responsibility to recognizing it as a chronic, complex disease influenced by biology, environment, and other underlying factors. “For almost 30 years, we have studied obesity not as a lifestyle issue, but as a chronic disease. Today is not just […]... Keep on reading: ‘Live Lighter’ movement debuts in PH as Novo Nordisk introduces new obesity drug, advances science-based care
Go to News Site